A new bufadienolide from Bufo gargarizans Cantor

Area of Science:

• Natural Product Chemistry
• Pharmacology
• Medicinal Chemistry

Background:

• Bufo gargarizans Cantor is a widespread toad species in China.
• Bufadienolides and indole alkaloids from B. gargarizans possess cardiotonic and anti-tumor properties.
• The dry skin of B. gargarizans is a source of pharmacologically important compounds.

Purpose of the Study:

• To isolate and identify bufadienolide compounds from the dry skin of B. gargarizans.
• To evaluate the in vitro cytotoxic activity of the isolated compounds.

Main Methods:

• Extraction and purification of compounds using various column chromatography techniques.
• Structure elucidation of isolated compounds using High-Resolution Electrospray Ionization Mass Spectrometry (HR-ESI-MS) and Nuclear Magnetic Resonance (NMR) spectroscopy.
• In vitro cytotoxic activity assay against A549 cells.

Main Results:

• A novel bufadienolide compound (1) and two known bufadienolides (gamabufotalin (2) and desacetylbufotalin (3)) were isolated and identified.
• Compound 1, named (2β,5β,16α)-2,5,16-trihydroxide bufa-14,20,22 dienolide, exhibited moderate cytotoxicity against A549 cells.
• The IC50 value for compound 1 against A549 cells was determined to be 12.65 μM.

Conclusions:

• The dry skin of Bufo gargarizans Cantor contains novel and known bufadienolides with cytotoxic potential.
• Compound 1 demonstrates moderate anti-cancer activity, suggesting its potential as a lead compound for further drug development.
• Further research is warranted to explore the pharmacological activities and mechanisms of action of these bufadienolides.